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Abstract
The abundance of two-component systems (TCSs) in Streptomyces coelicolor A3(2) genome indicates their importance in the
physiology of this soil bacteria. Currently, several TCSs have been related to antibiotic regulation, and the purpose in this
study was the characterization of five TCSs, selected by sequence homology with the well-known absA1A2 system, that
could also be associated with this important process. Null mutants of the five TCSs were obtained and two mutants
(DSCO1744/1745 and DSCO4596/4597/4598) showed significant differences in both antibiotic production and morphological
differentiation, and have been renamed as abr (antibiotic regulator). No detectable changes in antibiotic production were
found in the mutants in the systems that include the ORFs SCO3638/3639, SCO3640/3641 and SCO2165/2166 in any of the
culture conditions assayed. The system SCO1744/1745 (AbrA1/A2) was involved in negative regulation of antibiotic
production, and acted also as a negative regulator of the morphological differentiation. By contrast, the system SCO4596/
4597/4598 (AbrC1/C2/C3), composed of two histidine kinases and one response regulator, had positive effects on both
morphological development and antibiotic production. Microarray analyses of the DabrC1/C2/C3 and wild-type
transcriptomes revealed downregulation of actII-ORF4 and cdaR genes, the actinorhodin and calcium-dependent antibiotic
pathway-specific regulators respectively. These results demonstrated the involvement of these new two-component
systems in antibiotic production and morphological differentiation by different approaches. One is a pleiotropic negative
regulator: abrA1/A2. The other one is a positive regulator composed of three elements, two histidine kinases and one
response regulator: abrC1/C2/C3.
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Introduction
Antibiotics are highly valuable secondary metabolites that are
broadly produced in different species of the genus Streptomyces,a
filamentous soil bacterium with a complex life cycle. In fact, this
genus produces about half of all known microbial antibiotics [1].
The onset of antibiotic production depends on the growth stage of
the microorganism and usually takes place contemporaneous with
differentiation of the aerial mycelium into spores. Both differen-
tiation and antibiotic production can be triggered by many
environmental changes (physical and chemical), such as nutrient
deprivation, pH, temperature, etc. These changes must be sensed
and integrated in a cell response to promote rapid adaptation to
the new growth conditions. The quickest and most efficient
bacterial responses to extracellular stimuli occur via histidine-
aspartate (His-Asp) phosphorelay cascades. These systems are
made up of inner membrane-spanning protein kinases, which
sense the external environment, and their respective (cognate)
cytoplasmic response regulator partners, which generally exhibit
DNA-binding properties. Most of these signal transduction systems
only require a single sensor (HK: histidine kinase) and a cognate
response regulator (RR) and are thus referred to as two-
component systems (TCSs) [2]. Recently, some atypical systems
have been described, such as a kinase phosphorylated by GTP
instead of ATP [3] and the phosphorylation independent
activation response regulators, named PIARR [4–6].
S. coelicolor A3(2) is the best genetically studied Streptomyces strain
and has become the model organism for these species. The
complete sequence of its 8.7 Mb linear chromosome is available
(www.sanger.ac.uk [7]) [8] and contains 84 sensor kinase and 80
response regulator genes, 67 of which lie adjacent on the
chromosome and are predicted to form TCSs [9]. The mean
HK/RR (TCS) content of S. coelicolor (considering the whole 7825
ORFs) is 0.86% as compared with 0.65% for other free-living
microorganisms studied or 0.26% for pathogenic bacteria (25%
and 70% more in Streptomyces, respectively) [10]. This abundance
of TCSs could reflect the complexity of the regulatory network of
Streptomyces that would allow this genus to adapt and survive in
multiple and adverse environmental conditions.
S. coelicolor A3(2) produces at least four chemically distinct
antibiotics: actinorhodin (ACT), undecylprodigiosin (RED), calci-
um-dependent antibiotic (CDA) and methylenomycin, all of whose
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production responds to a hierarchy of different levels of decision,
distinguishing global or pathway-specific regulators [11]. Pathway-
specific regulators are part of the biosynthetic clusters (i.e., actII-
ORF4 for ACT [12]; redD for RED [13] and cdaR for CDA [14]).
Global regulators are located elsewhere and have the ability to
regulate operons that belong to different metabolic pathways, and
as a consequence mutants in these genes usually show pleiotropic
phenotypes. Among the global regulators there are some of which
are affecting different process such as differentiation and antibiotic
production (i.e. BldA [15], RelA [16], AbsB [17]) and others
reported just as global antibiotic regulators (i.e. AbsA1/A2 [18]).
TCSs usually act as global regulators that mediate the response
from external/internal stimuli to the final target genes.
The function of most of the 67 S. coelicolor TCSs is unknown;
only a few have an assigned role. Six of them have been reported
to modulate the antibiotic production and the best studied, absA1/
A2, is involved in their global regulation [14,18–21]. The aim of
this study was to determine the role of other five TCSs of S.
coelicolor, whose functions are as yet unknown. Four of them are
annotated as homologues to absA1/A2 in the Streptomyces
Annotation Server (http://strepdb.streptomyces.org.uk/ [22]).
The fifth TCS, although it showed less similarity with absA1/A2,
is an interesting system because it is composed of two HKs
and one RR and may be considered a three-component system.
A sequence comparison of this system with the available data-
bases indicated its conservation in almost all the species of
Streptomyces that are being sequenced by the Broad Institute (http://
www.broadinstitute.org/annotation/genome/streptomyces_group/
GenomeDescriptions.html).
In this study, the knockouts of the TCSs encoding genes (sensor
and regulator at the same time) were generated and the changes in
antibiotic production and morphological differentiation were
monitored in several medium cultures. Two of the five TCSs
selected (DSCO1744/1745 and DSCO4596/4597/4598) showed
significant differences in both antibiotic production and morpho-
logical differentiation, and have been renamed as abr (antibiotic
regulator). No changes in antibiotic production were detected in
the deletion mutants of the other three systems encoded by the
ORFs SCO3638/39, SCO2165/66 and SCO3640/41 in any of the
conditions tested. The mutant DSCO1744/45 showed a pleiotropic
phenotype. The ACT, RED, and CDA productions on some
media were triggered, suggesting a negative role of this system in
the antibiotic production. In addition, the morphological differ-
entiation was accelerated. An opposite pleiotropic phenotype was
revealed for the DSCO4596/97/98 mutant (TCS formed by two
HKs and one RR). This mutant showed a decrease in ACT, RED,
and CDA antibiotic productions and a delay in differentiation,
which indicates that this system is a positive global regulator of the
antibiotic production and differentiation. Microarray analyses of
the DSCO4596/97/98 and wild-type transcriptomes were per-
formed.
Results
Construction of null mutant strains
According to the annotations of the S. coelicolor database genome
(http://strepdb.streptomyces.org.uk/ [22]), five TCSs were select-
ed. Four of them, SCO1744/45, SCO2165/66, SCO3638/39,
and SCO3640/41, shared about 30% identity between their
corresponding HKs and that of the well-known global antibiotic
regulator absA1/A2, AbsA1. Additionally 50% identity was found
between their RRs and the AbsA2 regulator, which are considered
to be homologues (Table S1 and Table S2). The fifth one,
composed of two HKs (SCO4597 and SCO4598, which share
57% identity) and one RR (SCO4596), presented less similarity to
absA1/A2 (25% HKs-AbsA1 and 33% RR-AbsA2) but both HKs
were predicted to be functionally associated to AbsA1 using
STRING application (Search Tool for the Retrieval of Interacting
Genes/Proteins) (http://string.embl.de/newstring_cgi/show_in-
put_page.pl) [23] (AbsA1-SCO4598 association score of 0.726
just below the AbsA1–AbsA2 and AbsA1-RedZ scores, 0.949 and
0.923, respectively; AbsA1-SCO4597 association score of 0.691).
To determine the relevance of these five TCSs in antibiotic
production, null mutant strains of each system were obtained from
the S. coelicolor M145 strain by the REDIRECT procedure (see
Material and Methods). The correct replacement of the genes by
the cassette was confirmed by Southern blot hybridization using
appropriate DNA probes (data not shown).
To detect putative alterations in antibiotic production and/or
development of cells in the mutant strains compared to the wild
type, all of them were grown on several solid media at 30uC. The
media used were a minimal medium (NMMP) and different
complex media (NA, YEPD, R2YE, PGA and MSA).
Two of the five TCSs selected null mutant strains (DSCO1744/
45::accIV and DSCO4596/97/98::accIV) consistently displayed
significant differences in antibiotic production and differentiation
compared to the wild type (Figure 1). No differences were observed
in any conditions for the mutants of the systems SCO3638/39 and
SCO3640/41 (data not shown). The absence of the system
SCO2165/66 in the mutant seemed to slightly increase production
of the three antibiotics (ACT, RED, and CDA) in R2YE, PGA,
and NA media respectively but these results were difficult to
replicate and need further study (data not shown).
Clearly, the effect of mutations DSCO1744/45::accIV and
DSCO4596/97/98::accIV was medium-dependent, especially in
the production of ACT. Although differences could also be seen on
R2YE and YEPD media (data not shown), the strongest effects in
ACT production were on NMMP and on NA (Figure 1A, 1B).
Both mutants showed different phenotypes on both solid media:
the mutant DSCO1744/45::accIV displayed an ACT overproduc-
tion after three days’ growth, while DSCO4596/97/98::accIV strain
produced significantly less of this antibiotic molecule compared to
the wild type (Figure 1A, 1B). To quantify these observations,
liquid cultures were performed determining the rate growth and
ACT production of each strain in both media at different times. As
shown in Figure 1A (lower panel), the ACT production in the
mutant DSCO1744/45::accIV in liquid NMMP was increased more
than sixfold compared to the wild type at 96 h and the production
in the mutant DSCO4596/97/98::accIV was about the half of the
wild type. On the other hand, ACT production of DSCO4596/97/
98::accIV strain in NB was about 40% of that of the wild type but
less production of ACT in the mutant DSCO1744/45::accIV in NB
was also observed showing a more complex nutritional behaviour
of this mutant. The growth rates of the strains were similar in both
liquid media (Figure S1).
Differences in undecylprodigiosin production were also ob-
served on R2YE but mainly on PGA solid media (Figure 1C).
Quantification of RED production in PG liquid medium showed
that DSCO1744/45::accIV produces 67% more and DSCO4596/
97/98::accIV approximately 50% less compared to the wild-type
strain. As mentioned, this is not due to a growth defect because the
growth curves of the three strains were almost identical in the
culture conditions used (Figure S1).
CDA production, measured as the inhibition halo against
Bacillus subtilis, was evaluated on NA plates in the presence or
absence of calcium (see Materials and Methods) (Figure 1D). Once
again, DSCO1744/45::accIV had higher CDA production than the
TCS and Antibiotic Production in S. coelicolor
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and DSCO4596/97/98::accIV presented a decrease of 32% of the
inhibition halo.
Finally, YEPD was the medium used to document the
morphological development. DSCO1744/45::accIV mutant pre-
sented an accelerated formation of aerial mycelium, while
DSCO4596/97/98::accIV showed a clear delay in the differentia-
tion in these culture conditions (Figure 1E).
In summary, mutant DSCO1744/45::accIV overproduced the
three antibiotics and also showed a positive role in differentiation
(the aerial mycelia and spores appeared sooner than in the
wild-type strain). In contrast, strain DSCO4596/97/98::accIV
showed a decreased production of the antibiotics ACT, CDA,
and RED, and the differentiation was delayed.
From these results we can conclude that the two-component
systems composed by the ORFs: SCO1744/45 and SCO4596/97/
98, acted as antibiotic production regulators, and thus they were
called abrA1/A2, and abrC1/C2/C3, respectively.
Genetic complementation of TCSs null mutants
To make sure that the null mutant phenotypes observed were
due to the absence of TCSs genes and not to mutagenesis polar
Figure 1. Antibiotic production and differentiation of the different strains. Wild-type strain: S. coelicolor M145. Mutant strains: S. coelicolor
DabrA1/A2 and S. coelicolor DabrC1/C2/C3. A: ACT production on NMMP solid (top) and liquid (bottom) medium; B: ACT production on NA solid (top)
and NB liquid (bottom) medium; C: RED production on PGA solid (top) and liquid (bottom) medium; D: CDA production bioassay against B. subtilis on
NA solid medium (top) and inhibition halo diameter quantification (bottom); E: differentiation assay on YEPD (two days’ growth). S. coelicolor M145
(black columns), DabrA1/A2::aacIV (grey columns), DabrC1/C2/C3::aacIV (white columns). Error bars correspond to standard deviation of four
independent experiments.
doi:10.1371/journal.pone.0019980.g001
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the mutagenesis apramycin cassette of the each null mutant strain
(DabrA1/A2::accIV and DabrC1/C2/C3::accIV) was eliminated to
avoid possible polar effects (see Materials and Methods). The
resulting strains harboured a small scar (83 bp) in place of the
former antibiotic resistance sequence (DabrA1/A2 and DabrC1/
C2/C3) and displayed the same phenotypes as the original mutants
(data not shown).
The reverting strains were obtained by ectopic integration of
plasmids derived from pKC796Hyg in the WC31 attachment site:
pHabrA (whole system), pHabrC1/2/3 (whole system), pHabrC1/
3 (with a deletion in the gene encoding kinase AbrC2), and
pHabrC2/3 (with a deletion in the gene encoding kinase AbrC1)
(see Materials and Methods). Wild type and mutant strains with
the integrated pKC796Hyg plasmid were used as controls. It is
worth mentioning that integration of any plasmid in the WC31 site
provokes a decrease in the antibiotic production [24], especially on
NMMP medium. As shown in Figure 2, both DabrA1/A2
(pHabrA) and DabrC1/C2/C3 (pHabrC1/2/3) restored the
phenotypes of ACT production and differentiation of wt
(pKC796Hyg), although partially in the case of ACT production
in DabrC1/C2/C3 (pHabrC1/2/3) strain (Figure 2B). The
DabrC1/C2/C3 mutant phenotype could also be reverted by
complementation with pHabrC2/3 but not with pHabrC1/3
(Figure 2C) suggesting a more important role of HK AbrC2
(SCO4597) in the signalling network in this medium.
The reversion of the mutant phenotypes was also analysed using
multicopy plasmids derived from pN702GEM3 (high copy
number: 40–100 copies/genome) harbouring either abrA1/A2
(plasmid pNXabrA) or abrC1/C2/C3 genes (plasmid pNabrC) (see
Materials and Methods). When abrA1/A2 genes were expressed in
the multicopy plasmid the mutant phenotype was not only
reverted (Figure S2), but also antibiotic production (ACT, RED
and CDA) was even lower than in the wt (pN702GEM3).
Additionally, the strain DabrA1/A2 (pN702GEM3) had an
accelerated aerial mycelium formation, as opposed to DabrA1/A2
(pNXabrA) and wt (pN702GEM3) strains.
Unexpectedly, the DabrC1/C2/C3 (pNabrC) strain had even less
antibiotic production (ACT, RED, and CDA) than the mutant
DabrC1/C2/C3 (pN702GEM3) strain (Figure S3). However, when
the genes were expressed from a low copy number plasmid pAbrC
(derived from pHJL401 5–10 copies/genome see Materials and
Methods), both phenotypes, antibiotics production and morpho-
logical differentiation, were reverted (Figure S3).
Our results confirm that both systems have different roles in
regulation; while both affect antibiotic production and morpho-
logical differentiation pathways, the AbrA1/A2 is a negative
pleiotropic regulator and AbrC1/C2/C3 is a positive pleiotropic
regulator.
Microarray analysis of the DabrC1/C2/C3 strain
In order to determine the genes whose expression could be
affected by the lack of the three-component system, microarrays
assays comparing gene expression levels between DabrC1/C2/C3
and wild-type strains were performed. Total RNA preparations
were obtained from cultures (four replicates) grown for 50 h on
NA solid medium (see Materials and Methods). Statistical analysis
of the microarray results using limma provided a differential
expression value and an associated p-value for each gene. After
correction of these p-values for multiple testing (FDR or pdf, see
Materials and Methods), only a few genes were statistically
significant (p,0.05) (see Table 1). Most of them, however, encoded
either hypothetical proteins or proteins of putative functions,
which were not easily correlated with the phenotype observed. If
uncorrected p-values were considered (p,0.05), 201 genes
appeared to be upregulated and 202 genes downregulated in the
mutant strain. This set of genes should be taken with caution since
it might contain false positives. Nevertheless, certain genes showed
expression changes that could be correlated with phenotypic
observations or with a shared function. Thus, the lower antibiotic
production of the mutant DabrC1/C2/C3 was reflected in the
expression changes of structural and regulatory genes. Particularly,
the ACT and CDA pathway-specific regulators actIIORF4 and
cdaR were slightly downregulated (see Table 1). Semiquantitative
RT-PCR (see Materials and Methods) confirmed this (see
Materials and Methods). When compared to the wild-type strain
M145 the transcript levels of these genes in the mutant strain
decreased to 60% and 16%, respectively (Figure 3).
Therefore, the downregulation of the mentioned SARPs
encoding genes causes, at least partially, a decrease in ACT and
CDA production in DabrC1/C2/C3 as indeed the phenotypic
assays showed.
Figure 2. Mutant complementation. A: Complementation of
DabrA1/A2 phenotypes by the integrative plasmid pHabrA derived
from pKC796Hyg on NMMP. Top: morphological differentiation.
Bottom: ACT production. B: Complementation of DabrC1/C2/C3
phenotypes by the integrative plasmid pHabrC1/2/3 derived from
pKC796Hyg on NA (2 days). Top: morphological differentiation. Bottom:
ACT production. C: Complementation of DabrC1/C2/C3 phenotypes by
the integrative plasmid pHabrC1/3 and pHabrC2/3 derived from
pKC796Hyg on NA (3 days). Top: morphological differentiation. Bottom:
ACT production.
doi:10.1371/journal.pone.0019980.g002
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found (Table 1). Some genes encoding ribosomal proteins and
amino acid transporters proteins were downregulated in the
mutant strain, while the ribosomal recycling factor encoding gene
(frr, SCO5627) was upregulated.
Discussion
In this paper, we reported the study of five new TCSs from S.
coelicolor M145 and the involvement of two of them, named
AbrA1/A2 and AbrC1/C2/C3, in antibiotic production. Notori-
ously, the phenotype of both knockout strains was conditional.
This fact is not surprising since the TCSs are frequently aimed to
respond to specific environmental signals (i.e. AfsQ1-Q2-sigQ
[25]), which can be easily missed in some culture media or
conditions.
Additionally, our data show how both TCS systems studied
played pleiotropic roles in bacteria since not only affected different
antibiotic pathways but also different biological processes such as
morphological differentiation. Up to date most of the character-
ized TCSs in S. coelicolor have been reported to have an effect on
antibiotic production (i.e. CutR/S [26], EcrA1/A2 [27], PhoR/P
[28], AbsA1/A2 [18], RapA1/A2 [29]). However, just one among
them, (AfsQ1-Q2-sigQ) has been described to be involved in both
secondary metabolism and morphological development [25].
Figure 3. RT-PCR assays. S. coelicolor M145 and DabrC1/C2/C3 RNAm
amplification of actIIORF4 and RNA 16S (25 cycles) and cdaR (40 cycles)
by RT-PCR. Ribosomal RNA 16S amplification (25 cycles) was used as
control. Quantification of signal intensities is shown at the left.
doi:10.1371/journal.pone.0019980.g003
Table 1. Selected genes differentially expressed in the Microarray assay DabrC1/C2/C3 vs M145 by their p-value,0.05 and FDR/
pfp,0.05 or their biological meaning (italics).
SCO/name Function Fold change p-value p-value FDR/pfp
Upregulated 0122 Putative flavin containing monooxygenase 2.31 0.022 0.038
0277 Hypothetical protein 2.83 0.0012 0.0225
0850 Putative membrane protein 3.23 0.0003 ,0.001
3309 Hypothetical protein 2.26 0.048 0.030
6259 Probable ABC sugar transport 2.96 0.0178 0.040
6557 Putative neuramidase 2.32 0.0029 0.030
5627 Ribosome recycling factor 1.8 0.0003 0.232
Downregulated 4559 Putative electrontransfer oxidoreductase 22.88 0.0053 ,0.001
4612 Putative amino acid transporter 22.57 0.0096 0.02
5085/actIIORF4 Actinorhodin cluster activator protein 21.3 0.048 0.897
5089/actIORF3 Actinorhodin polyketide synthase acyl carrier protein 21,72 0,0017 0.325
3217/cdaR Transcriptional activator protein 21.4 0.0009 0.777
0708 Putative branched-chain amino acid transport protein 21.63 0.027 0.332
1599/rpmI 50S ribosomal protein 21.8 0.0036 0.333
1998/rpsA 30S ribosomal protein 21.65 0.0252 0.357
2563/rpsT 30s ribosomal protein 21.78 0.0023 0.322
2596/rpmA 50S ribosomal protein 21.6 0.0412 0.407
3023 Adenosylhomocysteinase 21.5 0.0004 0.545
3427/rpmE Putative 50S ribosomal protein 22.19 0.012 0.180
3430/rpsN Putative 30S ribosomal protein 21.73 0.0074 0.357
3908/rpsR Putative 30S ribosomal protein 22 0.01 0.220
4661/fusA Elongation factor G 21.8 0.0039 0.273
4703/rplD 50S ribosomal protein 21.82 0.04 0.213
4718/rplR 50S ribosomal protein 21,6 0.037 0.453
4721/rplO 50S ribosomal protein 21.62 0.045 0.386
5591/rpsP 30S ribosomal protein 21.75 0,029 0.333
doi:10.1371/journal.pone.0019980.t001
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A2 (SCO1744/45) overproduced the three antibiotics tested in a
medium dependent manner. This fact makes this system extremely
interesting since it could be used to overproduce clinical useful
antibiotics by expressing abrA1/A2 alleles in heterologous
streptomycetes as has been recently reported for the system
AbsA1/A2 [30]. Interestingly, this system only has an orthologue
in S.lividans being absent in all the other Streptomyces species
sequenced to date. However, the S. lividans knockout does affect
neither antibiotic production nor morphological differentiation
(data not shown). Therefore, this system seems to represent a S.
coelicolor specific antibiotic regulator.
The system, AbrC1/C2/C3, must be considered special
because it has two kinases and one regulator. Besides, each gene
is separated from the upstream ORF by a DNA sequence long
enough to have its own promoter (286, 112, and 171 nt,
respectively). Therefore, each gene might be expressed indepen-
dently in order to suit its own needs. This system is conserved in all
the Streptomyces species sequenced so far as well as in the ones those
are in the process of being sequenced. Furthermore, the response
regulator protein SCO4596 shares about 80% identity at the
amino acid level in all the species. This consistently indicates an
important role for this special system.
Our data demonstrate that the deletion of the three genes
originates a strain with reduced capacity to produce the three
antibiotics studied, ACT, RED, and CDA. Similar phenotypes
were obtained with the expression of these three genes in a high
copy number plasmid but not in a low copy number where the
phenotypes were reverted to the wild type ones (Figure S3),
showing that this effect was dose dependent. On the contrary, the
mutant phenotype with respect to morphological differentiation
was reverted even in multicopy number plasmid (Figures 2 and
S3). This suggests that separate mechanisms underlie the effects of
AbrC1/C2/C3 on antibiotic production and differentiation, as
was found with AbsB protein [31].
Microarray analysis and RT-PCR studies demonstrated the role
of AbrC1/C2/C3 over antibiotic production was at least partly
through transcription of pathway-specific regulator genes ac-
tIIORF4 and cdaR. However, with the data obtained to date, we
cannot determine whether this is a direct regulation due to the
binding of AbrC3 to the specific promoters of the pathway
regulators or an indirect effect through a complex regulatory
network. Therefore, deeper studies will be performed to
understand the role of this TCS in the regulation of antibiotic
production in the pigmented streptomycete S. coelicolor. Expression
differences between DabrC1/C2/C3 mutant and wild-type strains
have also been found in genes associated with translation
machinery. We hypothesized that a lower expression of some
ribosomal protein genes (9 out of 62) in the mutant may affect the
synthesis of proteins needed for the production of antibiotics, and
in response cells try to compensate this by increasing the ribosomal
recycling factor. The relation between enhanced protein synthesis
during the stationary phase and the expression of regulatory
proteins governing antibiotic production has been suggested
previously [32,33]. In addition, previous work has correlated the
ribosomal proteins and the frr overexpression with ACT
production [34] and more recently with avermectin overproduc-
tion [35].
It is widespread known that antibiotic production in S. coelicolor
is a complex process that is regulated by a broad network of genes.
In this paper two new two-component global regulators in this
network have been identified. It is noteworthy that, they are
among the very few TCSs identified on S. coelicolor that are
affecting two different but related processes: the antibiotic
production and developmental differentiation. One, abrA1/A2,i s
a negative regulator; the other, abrC1/C2/C3, a three-component
system composed by two HKs and one RR, is a positive regulator.
Materials and Methods
Strains, media and culture conditions
Escherichia coli strains growth was accomplished as described
previously [36]. BW25113 (pIJ790) (containing the lRed system) is
an E. coli K12 (DaraBAD, DrhaBAD) derivative [37]; non-
methylating ET12567 (pUZ8002) is dam, dcm, hsdS, cat, tet
containing the atra genes [38] and E. coli DH5a (pBT30) is recA,
cat, bla containing flp gene [37]. For CDA bioassays a wild-type
strain of Bacillus subtilis (CECT 4522) was grown as an overlay on
NA medium. S. coelicolor M145 (prototroph, SCP1
2, SCP2
2,
methylenomycin
2) and its mutant strain derivatives were grown
on R2YE, NA, MSA, PGA, YEPD, and NMMP [39]. Liquid
cultures were performed in 100 ml baffled flasks with 15 ml
medium each. When necessary, the medium was supplemented
with antibiotics (E.coli media: 100 mgm l
21 for ampicillin,
50 mgm l
21 for apramycin, 50 mgm l
21 for kanamycin,
34 mgm l
21 for chloramphenicol, and 25 mgm l
21 for nalidixic
acid. S. coelicolor media: 20 mgm l
21 for neomycin and 20 mgm l
21
for hygromycin).
Isolation and manipulation of DNA
Plasmid isolation, restriction enzyme digestion, ligation, and
transformation of E. coli and S. coelicolor were carried out by
methods of Sambrook et al [40] and Kieser et al [39], respectively.
The plasmids and cosmids used are listed in Table 2. Total
genomic DNA from S. coelicolor (gDNA) was isolated from a 24–
36 h cultures in TSB medium following the procedure described
in Hopwood et al [41], but scaled to 1–2 g of mycelium.
Deletion of the TCSs selected
REDIRECT PCR-targeting technology [42] was used to
replace the genes of the entire coding region of each TCS
(comprising histidine kinase and response regulator) to an
apramycin (aac(3)IV gene) resistance cassette. Mutagenic cassettes
were flanked by the recognition sequence of E. coli Flipase (FRT)
and contained the conjugation transfer origin oriT (FRT-aac(3)IV-
oriT-FRT) and were amplified using the High-Fidelity Expand
PCR system (Roche Co.) with the primers listed in Table S3 using
plasmid pIJ773 as template. The generated cassettes were
introduced into E. coli BW25113 (pIJ790) harbouring the
appropriate cosmid for each studied system (Table 2: SCI11,
SC5F7, SCH10 and SCD20; http://strepdb.streptomyces.org.uk/
[22]) and preinduced for lRed functions, by the addition of
arabinose, to obtain a target gene-disrupted version of the mutant
cosmids. The disrupted cosmids, confirmed by restriction analysis,
were isolated and transferred from E. coli ET12567 (pUZ8002) to
S. coelicolor M145 by conjugation. Exconjugants were selected on
MSA medium containing apramycin (50 mgm l
21), and the double
crossover products identified by screening their sensitivity to
kanamycin (50 mgm l
21). The disruptions were confirmed by
Southern hybridization and the DIG DNA labelling and detection
kit (Roche Co.) was used for probe preparation (obtained with
primers of Table S3).
To avoid putative polar effects of the mutagenesis cassette gene
replacement in S. coelicolor M145, the antibiotic resistant marker
and the oriT region were eliminated in two steps. In a first step, the
corresponding disrupting cosmids were introduced in E. coli DH5a
(pBT30) strain (harbouring the Flipase gene, FLP) in which, the
recombination between both FRT mutagenesis cassette-flanking
TCS and Antibiotic Production in S. coelicolor
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(SCAR) remained in frame with the adjacent ORFs. Afterwards,
in the second step, the SCAR cosmids were transferred to the
Streptomyces apramycin-resistance mutant strains by protoplast
transformation, selecting neomycin-resistance clones in the first
place (unique recombination). Finally the strains were apramycin
and neomycin-sensitive (double recombination). PCR assays
confirmed the correct recombination in the new Streptomyces
mutant strains.
Plasmid constructions
All the plasmids used in this work are listed in Table 2.
Integrative plasmid pHabrA was obtained by cloning PCR-
amplified abrA1/A2 genes and their own promoter in the shuttle
Streptomyces integrative plasmid pKC796Hyg [43]. In the
intermediate pAY001 plasmid, the promoter PCR fragment
was amplified with primers AY-033 (adding an EcoRI site), and
AY-034 (adding an NdeI site) (Table S3), using SCI11 as a
template, was cloned in pXHis1 plasmid [44]. pAY002 derivative
plasmid harbours the pair of genes amplified by PCR with
primers AY-035 (additional NdeI site) and AY-036 (adding an
XhoI site) in the NdeI/XhoI sites of pAY001 plasmid. Fragment
BglII/BglII from pAY002 was finally cloned in pKC796Hyg
plasmid, yielding pHabrA plasmid.
pNXabrA plasmid was obtained by cloning the fragment NdeI/
HindIII from pAY002 plasmid in the sites of the pNX24 plasmid
(pN702GEM3 derivative [45]). In this shuttled (E.coli-Streptomyces)
multicopy plasmid the xylanase promoter xysAp controls abrA1/A2
gene expression.
The three genes abrC1/C2/C3, and their intergenic regions
were cloned in a pN702GEM3 plasmid yielding a multicopy
plasmid in several steps. An intermediate E. coli monofunctional
plasmid called pSCD20 was constructed by cloning a BspEI/
PmII fragment from a subclone of SCD20 cosmid in the BspEI/
Ecl136II sites of pHJL401 [46]. Afterwards, the fragment
EcoRV/HindIII from pSCD20 was introduced in pN702GEM3
to get pNabrC. The low copy number pAbrC plasmid derived
from pHJL401 [46] was obtained by cloning the BglII/HindIII
fragment from pNabrC in the BamHI/HindIII sites of
pHJL401.
To obtain the integrative plasmid for mutant DabrC1/C2/C3
complementation, pNSCD20 was digested with HindIII, filled
with Klenow polymerase, and BglII digested. This fragment was
inserted into the BlgII/EcoRV sites of pKC796Hyg to get
pHabrC1/2/3. Plasmid with abrC1 gene disrupted was got by
digesting pHabrC1/2/3 with XhoI and religated (eliminating a
fragment of 260 nt containing the promoter and the 59 end of
the gene), yielding pHabrC2/3. To disrupt abrC2 gene an inner
Table 2. Plasmids and cosmids used in this work.
Vector Characteristics Reference
pIJ790 l-RED (gam, beta, exo), cat, araC, rep101
ts [42]
pIJ773 aac(3)IV (Apra
R)+oriT, FRT sites [42]
pUZ8002 tra, neo, RP4 [51]
SCI11 Supercos-1 derivative: bla, neo. Contains genes SCO1744/45 [52]
SC5F7 Supercos-1 derivative: bla, neo. Contains genes SCO2165/66 [52]
SCH10 Supercos-1 derivative: bla, neo. Contains genes SCO3638/39/40/41 [52]
SCD20 Supercos-1 derivative: bla, neo. Contains genes SCO4596/97/98 [52]
DSCI11-1 SCI11 DSCO1744/45::aac(3)IV This work
DSC5F7-1 SC5F7 DSCO2165/66::aac(3)IV This work
DSCH10-1 SCH10 DSCO3638/39::aac(3)IV This work
DSCH10-2 SCH10-2 DSCO3640/41::aac(3)IV This work
DSCD20-1 SCD20 DSCO4596/97/98::aac(3)IV This work
DSCD20-1 SCAR SCD20 DSCO4596/97/98 This work
DSCI11-1 SCAR SCI11 DSCO1744/45 This work
pXHis1 E. coli plasmid Amp resistance [45]
pAY001 pXHis1 derivative containing promoter region of SCO1744/45 This work
pAY002 pAY001 derivative containing SCO1744/45 This work
pN702GEM3 E. coli–Streptomyces shuttle vector; Neo/Kan resistance [45]
pNXabrA pN702GEM3 derivative containing SCO1744/45 This work
pNabrC pN702GEM3 derivative containing SCO4596/97/98 This work
pHJL401 E. coli–Streptomyces shuttle vector; Amp/Tsr resistance [46]
pAbrC pHJL401 derivative containing SCO4596/97/98 This work
pKC796Hyg Integrative plasmid with hygromycin resistance [43]
pHabrA pKC796Hyg derivative containing SCO1744/45 This work
pHabrC1/2/3 pKC796Hyg derivative containing SCO4596/97/98 This work
pHabrC1/3 pKC796Hyg derivative containing SCO4596/98 This work
pHabrC2/3 pKC796Hyg derivative containing SCO4596/97 This work
doi:10.1371/journal.pone.0019980.t002
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SfiI/AgeI sites and by treatment with T4 DNA polymerase
before ligation, the plasmid got was named pHabrC1/3.
The new plasmids were introduced into the corresponding
strains by protoplast transformation as previously described [39].
Antibiotic determination
Antibiotic production was assayed on solid media as described
below. Plates were inoculated with 10
3 spores streaked or added to
a5ml drop. For CDA production the strains were grown on NA
medium at 30uC for 2 days. Afterwards, the plates were overlaid
with 5 ml of soft agar plus 60 mM Ca(NO3)2 inoculated with B.
subtilis as the test microorganism (0.2 ml, 0.25 DO) and incubated
at 30uC for 20 h. A replica plate without calcium was used as a
negative control. For ACT production on solid media, the strains
were grown on different media (YEPD, R2YE, NMMP, NA) at
30uC for at least 3 days to observe the blue halo around the
colonies. RED production was detected on PGA medium after 2
days as the red colour of colonies.
The ACT and RED antibiotic productions were quantified in
liquid cultures using the standard spectrophotometric method [39]
with minor modifications. 15 ml of medium were inoculated with
4610
6 spores/ml. Culture samples were mixed with 1N KOH
overnight at 4uC, centrifuged (15000 g, 10 min), and A640 of
supernatants were determined to quantify ACT (e640=25320). To
quantify RED, pellets were washed twice in 0.5 M HCl and
extracted in 0.5 M HCl-methanol for 2 h. After centrifugation
(15000 g, 5 min), supernatant’ absorbance were measured
(e530=100500). Dry weight of samples at different times was
measured to monitor culture growth.
Microarrays assays
For RNA extraction from S. coelicolor wild-type and DabrC1/C2/
C3 mutant strains, NA plates covered with a cellophane sheet were
inoculated with 7.5610
6 spores and incubated at 30uC for 50 h.
Prior to RNA isolation using a RNeasy Midi Kit (Quiagen) the
mycelia was harvested and suspended in RNA-protect Bacteria
Reagent (Qiagen). An additional step with RNase free DNase
(Qiagen) was incorporated to remove any contaminating DNA.
The quality and concentration of RNA were assayed using gel
electrophoresis and spectrophotometer assays (Q-bit and Agilent
bioanalizer). Four biological replicates were used.
cDNA versus gDNA microarrays experiments were chosen due
to the advantages described elsewhere [47,48]. The S. coelicolor
SCo40 microarrays used were obtained from the Functional
Genomics Laboratory of Surrey University (UK) [49]. The
Pronto! Universal Microarray Hybridization kit (Corning, #
40026) was used for pretreatment and prehybridization. Cy3-
cDNA and Cy5-gDNA labelling reactions were performed
according to the recommendations described by http://www.
surrey.ac.uk/SBMS/Fgenomics [49]. Hybridization assays were
done as in Rodrı ´guez-Garcı ´a et al. [28] and TIFF images were
generated by Genepix DNA Microarray Scanner 4000B and
processed with Genepix Pro 4.0 software. Bioconductor software
package limma (linear models for microarray analysis) and rank
products were used to analyse and assess the statistical
significance of the data [28,50]. Background correction was
applied using the normexp function. Then, the log of Cy3/Cy5
intensities were normalized using block-weighted medians and
global loess. The different p-values of the contrast between both
strains were corrected for multiple testing FDR (false discovery
rate) or by the rank products pfp method (proportion of false
positives). To consider a gene differentially expressed, it should
have passed at least one of these criteria: limma FDR-corrected p-
value,0.05 or rank products pfp value,0.05. All data is MIAME
compliant and the raw data has been deposited in a MIAME
compliant database (ArrayExpress, accession number E-MEXP-
2841)
Semiquantitative RT-PCRs
RT-PCR assays were performed with 200 ng RNA in a final
volume of 20 ml with the Superscript
TM One-Step RT-PCR with
PlatinumH Taq System Kit (Invitrogen). The primers used are
specified in Table S3. Reactions were made as follows: 30 min at
55uC (cDNA synthesis); 2 min at 95uC; 20–40 cycles: 45 sec at
94uC, 30 sec at 65uC and 40 sec at 65uC; 10 min at 72uC. To
check the DNA absence in the RNA samples, similar reactions
avoiding the cDNA synthesis step were done in parallel. 2 mlo f
each reaction were run in 1.6% agarose gel buffered with TAE
16. Each set of reactions was repeated varying the number of
cycles to ensure that the PCR had not reached the plateau phase.
As a positive internal control RT-PCR of 16S RNA was used. RT-
PCR band images were quantified using Quantity One Analysis
software 4.6.6 (Bio-Rad).
Supporting Information
Table S1 Identity percentages among the sensor kinas-
es by a local alignment (Emboss).
(DOC)
Table S2 Identity percentages among the response
regulators by a local alignment (Emboss).
(DOC)
Table S3 Primers used in this work.
(DOC)
Figure S1 Growth curves of the different strains in
NMMP (A), NB (B) and PGA (C) S. coelicolor M145 (triangles), S.
coelicolor DabrA1/A2 (circles) and S. coelicolor DabrC1/C2/C3
(squares). Error bars correspond to standard deviation of two
independent experiments measured by duplicate.
(TIF)
Figure S2 Phenotypes of strains expressing abrA1/A2 in
multicopy plasmid. A: Effect of the expression of abrA1/A2
genes by the high copy number plasmid pNXabrA derived from
pN702GEM3 on NMMP medium. Top: morphological differ-
entiation. Bottom: ACT production. B: CDA bioassays on NA
medium, RED production on PGA medium, and morphological
differentiation on YEPD medium (2 days), in the different
strains.
(TIF)
Figure S3 Phenotypes of strains expressing abrC1/C2/
C3 in multicopy plasmids. A: Effect of expression of abrC1/
C2/C3 genes by the high copy number plasmid pNabrC derived
from pN702GEM3: ACT production on NA medium, CDA
bioassays on NA medium, RED production on PGA medium,
and MD morphological differentiation on YEPD medium (2
days), by the different strains. B: Effect of expression of abrC1/
C2/C3 genes by the low copy number pAbrC plasmid derived
from pHJL401: ACT production on NA medium, CDA bioassays
on NA medium, RED production on PGA medium, and MD
morphological differentiation on YEPD medium (3 days), by the
different strains.
(TIF)
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